Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postoperative Complications and Long-Term Cardiovascular Risk After Gastrectomy for Gastric Cancer.

Annals of surgical oncology·2026
Same author

Cardiovascular Disease Risk Among Young Adults with Disabilities: A Nationwide Cohort Study.

European journal of preventive cardiology·2026
Same author

SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma.

Oncology research·2026
Same author

Residential green space and incidence of cardiovascular disease: Evidence from a nationwide population-based study.

International journal of hygiene and environmental health·2026
Same author

Genipin-crosslinked CeO<sub>2</sub>-incorporating Janus patch for oral ulcer treatment.

RSC advances·2026
Same author

SIGMA: Shear-induced gelation by microbead aggregation in tubular flow systems.

Materials today. Bio·2026

Related Experiment Video

Updated: Jun 10, 2025

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

7.6K

Synergistic effect of ROS-generating polydopamine on drug-induced bone tissue regeneration.

Hyeju Han1,2, Bongkyun Kang2, Shazid Md Sharker3

  • 1Department of Chemistry, Kyungpook National University, Daegu 41566, South Korea. kyueui@knu.ac.kr.

Nanoscale
|October 15, 2024
PubMed
Summary

This study developed a novel polydopamine (PDA) drug delivery system for 1,4-dihydrophenonthrolin-4-one-3-carboxylic acid (1,4-DPCA). This system significantly enhanced bone regeneration by over sixfold in mice.

More Related Videos

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
07:53

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects

Published on: December 10, 2010

18.0K
Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
09:34

Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair

Published on: September 7, 2017

9.3K

Related Experiment Videos

Last Updated: Jun 10, 2025

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

7.6K
Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
07:53

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects

Published on: December 10, 2010

18.0K
Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
09:34

Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair

Published on: September 7, 2017

9.3K

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Drug Delivery Systems

Background:

  • Prolyl hydroxylase (PHD) inhibitors, like 1,4-dihydrophenonthrolin-4-one-3-carboxylic acid (1,4-DPCA), promote tissue regeneration by upregulating hypoxia-inducible factor 1 subunit alpha (Hif-1α).
  • Developing effective drug delivery systems is crucial for maximizing the therapeutic potential of regenerative agents.

Purpose of the Study:

  • To design a novel polydopamine (PDA)-based drug delivery system for 1,4-DPCA.
  • To investigate the synergistic effects of PDA-generated reactive oxygen species (ROS) and 1,4-DPCA on tissue regeneration.

Main Methods:

  • Encapsulation of 1,4-DPCA within PDA nanoparticles.
  • Evaluation of Hif-1α upregulation and cellular antioxidant defense mechanisms.
  • Assessment of bone regeneration in a mouse calvarial defect model.

Main Results:

  • The combined PDA and 1,4-DPCA system demonstrated a synergistic effect on regenerative mechanisms.
  • Localized ROS generation by PDA enhanced cellular antioxidant defenses.
  • A sixfold increase in bone regeneration was observed compared to the control group.

Conclusions:

  • PDA serves as an effective drug delivery vehicle for 1,4-DPCA, enhancing its regenerative properties.
  • The developed system offers a promising strategy for significantly improving bone tissue regeneration.